Mass. Federal Judge Denies GSK Summary Judgment in 50 Zofran Cases

BOSTON — A Massachusetts federal judge has denied GlaxoSmithKline’s motion for summary judgment in 50 cases on the Zofran multidistrict litigation docket, finding the plaintiffs presented sufficient evidence that the drug can cause orofacial abnormalities other than cleft palate.

In an Oct. 23 order, Judge F. Dennis Saylor IV of the U.S. District Court for the District of Massachusetts explained that testimony from the plaintiffs’ causation experts created a genuine dispute that Zofran can cause cleft lip with or without cleft palate.

Plaintiffs are parents and guardians of children who were born with birth defects allegedly caused by prenatal exposure …